InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Friday, 05/01/2015 6:58:16 PM

Friday, May 01, 2015 6:58:16 PM

Post# of 2099
Potential for VB-201 in Atherosclerosis
Although based on the clinical results described above we have discontinued development of VB-201 for psoriasis and ulcerative colitis, based on the early clinical work described below, we believe VB-201 may have potential for the treatment of atherosclerosis.

We are currently evaluating whether to develop VB-201 in atherosclerosis or other indications, and we continue to investigate other potential Lecinoxoids for development as well, but in the near term we intend to focus substantially all of our efforts and resources on advancing our oncology program.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News